Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists - PubMed (original) (raw)
Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists
K S Frederiksen et al. J Mol Endocrinol. 2003 Jun.
Abstract
Peroxisome proliferator activated receptor (PPAR)-alpha controls the expression of multiple genes involved in lipid metabolism, and activators of PPAR-alpha, such as fibrates, are commonly used drugs in the treatment of hypertriglyceridemia and other dyslipidemic states. Recent data have also suggested a role for PPAR-alpha in insulin resistance and glucose homeostasis. In the present study, we have assessed the transcriptional and physiological responses to PPAR-alpha activation in a diet-induced rat model of insulin resistance. The two PPAR-alpha activators, fenofibrate and Wy-14643, were dosed at different concentrations in high-fat fed Sprague-Dawley rats, and the transcriptional responses were examined in liver using cDNA microarrays. In these analyses, 98 genes were identified as being regulated by both compounds. From this pool of genes, 27 correlated to the observed effect on plasma insulin, including PPAR-alpha itself and the leukocyte antigen-related protein tyrosine phosphatase (PTP-LAR). PTP-LAR was downregulated by both compounds, and showed upregulation as a result of the high-fat feeding. This regulation was also observed at the protein level. Furthermore, downregulation of PTP-LAR by fenofibric acid was demonstrated in rat FaO hepatoma cells in vitro, indicating that the observed regulation of PTP-LAR by fenofibrate and Wy-14643 in vivo is mediated as a direct effect of the PPAR agonists on the hepatocytes. PTP-LAR is one of the first genes involved in insulin receptor signaling to be shown to be regulated by PPAR-alpha agonists. These data suggest that factors apart from skeletal muscle lipid supply may influence PPAR-alpha-mediated amelioration of insulin resistance.
Similar articles
- Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta.
Gervois P, Vu-Dac N, Kleemann R, Kockx M, Dubois G, Laine B, Kosykh V, Fruchart JC, Kooistra T, Staels B. Gervois P, et al. J Biol Chem. 2001 Sep 7;276(36):33471-7. doi: 10.1074/jbc.M102839200. Epub 2001 Jun 20. J Biol Chem. 2001. PMID: 11418615 - Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
Sterchele PF, Sun H, Peterson RE, Vanden Heuvel JP. Sterchele PF, et al. Arch Biochem Biophys. 1996 Feb 15;326(2):281-9. doi: 10.1006/abbi.1996.0077. Arch Biochem Biophys. 1996. PMID: 8611035 - Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity.
Guerre-Millo M, Gervois P, Raspé E, Madsen L, Poulain P, Derudas B, Herbert JM, Winegar DA, Willson TM, Fruchart JC, Berge RK, Staels B. Guerre-Millo M, et al. J Biol Chem. 2000 Jun 2;275(22):16638-42. doi: 10.1074/jbc.275.22.16638. J Biol Chem. 2000. PMID: 10828060 - Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
Fruchart JC, Duriez P, Staels B. Fruchart JC, et al. Curr Opin Lipidol. 1999 Jun;10(3):245-57. doi: 10.1097/00041433-199906000-00007. Curr Opin Lipidol. 1999. PMID: 10431661 Review. - PPAR: a mediator of peroxisome proliferator action.
Green S. Green S. Mutat Res. 1995 Dec;333(1-2):101-9. doi: 10.1016/0027-5107(95)00136-0. Mutat Res. 1995. PMID: 8538617 Review.
Cited by
- The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.
Martin GG, McIntosh AL, Huang H, Gupta S, Atshaves BP, Landrock KK, Landrock D, Kier AB, Schroeder F. Martin GG, et al. Biochemistry. 2013 Dec 23;52(51):9347-57. doi: 10.1021/bi401014k. Epub 2013 Dec 10. Biochemistry. 2013. PMID: 24299557 Free PMC article. - Divergence between human and murine peroxisome proliferator-activated receptor alpha ligand specificities.
Oswal DP, Balanarasimha M, Loyer JK, Bedi S, Soman FL, Rider SD Jr, Hostetler HA. Oswal DP, et al. J Lipid Res. 2013 Sep;54(9):2354-65. doi: 10.1194/jlr.M035436. Epub 2013 Jun 24. J Lipid Res. 2013. PMID: 23797899 Free PMC article. - High glucose potentiates L-FABP mediated fibrate induction of PPARα in mouse hepatocytes.
Petrescu AD, McIntosh AL, Storey SM, Huang H, Martin GG, Landrock D, Kier AB, Schroeder F. Petrescu AD, et al. Biochim Biophys Acta. 2013 Aug;1831(8):1412-25. doi: 10.1016/j.bbalip.2013.05.008. Epub 2013 Jun 6. Biochim Biophys Acta. 2013. PMID: 23747828 Free PMC article. - New treatments for chronic hepatitis C.
Jang JY, Chung RT. Jang JY, et al. Korean J Hepatol. 2010 Sep;16(3):263-77. doi: 10.3350/kjhep.2010.16.3.263. Korean J Hepatol. 2010. PMID: 20924208 Free PMC article. Review. - Glucose regulates fatty acid binding protein interaction with lipids and peroxisome proliferator-activated receptor α.
Hostetler HA, Balanarasimha M, Huang H, Kelzer MS, Kaliappan A, Kier AB, Schroeder F. Hostetler HA, et al. J Lipid Res. 2010 Nov;51(11):3103-16. doi: 10.1194/jlr.M005041. Epub 2010 Jul 13. J Lipid Res. 2010. PMID: 20628144 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous